An immunoassay is a chemical test used to detect or quantify a specific substance using an immunological reaction. Immunoassays are utilized in healthcare industry in diagnostics applications, such as infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, neonatal screening, and in toxicology testing. The immunoassay market is expected […]Read More..
The Next-generation Sequencing Services Market is expected to grow at a CAGR of 20.4% from 2021 to 2028 to reach $14.1 billion by 2028. Next generation sequencing (NGS) refers to a DNA sequencing technology that has revolutionized genomic research. The potential capabilities of NGS allow the entire human genome sequence in a single day. Genome […]Read More..
he global next-generation sequencing (NGS) market is expected to grow at a CAGR of 16.2% from 2019 to reach $10.35 billion by 2025. The field of genomics has surpassed expectations over the past three decades due to massive changes in technology that allowed researchers to interrogate larger pieces of the human genome. Next Generation Sequencing […]Read More..
Cloning is a process used to produce genetically identical copies of a biological entity. These copies are referred to as clones. Since last decade, researchers are cloning a wide range of biological material namely genes, cells, tissues, or entire organisms. For this, the natural competence of a cell or bacteria or genome is highly important […]Read More..
The global point of care (POC) molecular diagnostics market is expected to grow at a CAGR of 13.2% from 2019 to 2027 to reach at $2.39 billion by 2027 POC molecular diagnostics include portable devices and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood, serum, and stool. […]Read More..
The global in-vitro toxicology testing market is expected to grow at a CAGR of 9% from 2019 to reach $14.4 billion by 2025. Safety assessment of substances is essential to determine their toxic implications on humans and the environment. Toxicology studies evaluate the substances to determine if they are safe to use by humans and […]Read More..
With the growing need for early disease diagnosis and improved patient outcomes, in-vitro diagnostics is shifting from centralized laboratories to decentralized point-of-care (POC) testing. POC testing is gaining traction as it enables rapid detection of analytes near to the patient, which facilitates quick medical decisions and better disease diagnosis, monitoring, and management. The global point […]Read More..
The influenza diagnostics market is expected to grow at a CAGR of 7.9% from 2020 to 2027 to reach at $1.17 billion by 2027. Influenza which is commonly known as “the flu”, is an infectious disease caused by an influenza virus. It is spread in all population more specifically in people with weak immune response. […]Read More..
The research antibodies and reagents market is expected to grow at a CAGR of 5.6% from 2020 to 2027 to reach USD 6.32 billion by 2027, Says “Meticulous Research®”. Due to high specificity, binding affinity, long half-lives, and low toxicity, antibodies are considered as an effective tool for research, diagnostic, and therapeutic purposes. Antibodies are […]Read More..
Immunotherapy is one of the most recent approaches for cancer therapy. It is a treatment that uses body’s own immune system to help fight cancer. It is widely used in hospital settings and clinics for the treatment of different types of cancers such as lung cancer, breast cancer, colorectal cancer, multiple myeloma, melanoma, prostate cancer, […]Read More..